Skip to content
GRAPHORA
Menu

PUBLIC COMPANY OVERVIEW · Diabetes testing

Digostics

Digostics develops at-home oral glucose tolerance testing and related diagnostic services.

What the company does

Its GTT@home platform is designed to bring a test normally associated with a clinical setting into a home-based workflow. The public materials discuss working with healthcare providers to improve access to testing. This combines a diagnostic product with logistics, instructions and the return of useful results to care teams. Readers should use current clinical guidance and the provider’s instructions rather than this company overview for health decisions.

Areas to understand

These themes describe the company’s public focus, not a personalized fit rating. Members bring their own experience, interests and questions to the review process.

Where it fits on Graphora

This company is presented within Healthcare Shares & Red Sky Health. Explore that strategy to see related public overviews, then use your Graphora membership to review available opportunity details.

MAKE IT PERSONAL

Explore Digostics as a member.

Create your Graphora profile or sign in to review available opportunity information. Confidential materials stay protected. Access and investment participation depend on the applicable requirements, not membership alone.

Join / Sign in to explore ↗